Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.29%||79.74||0.9%||$563.79m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.06%||126.75||2.0%||$276.96m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.50%||343.30||2.7%||$275.56m|
|VRTX||Vertex Pharmaceuticals Incorporated||0.97%||175.66||1.9%||$265.02m|
|A||Agilent Technologies, Inc.||-0.43%||69.88||1.5%||$176.42m|
|EXAS||Exact Sciences Corporation||0.92%||52.57||25.7%||$143.36m|
|SRPT||Sarepta Therapeutics, Inc.||-0.37%||80.92||16.7%||$123.27m|
|BLUE||Bluebird Bio, Inc.||-6.92%||199.80||15.8%||$122.80m|
|BMRN||BioMarin Pharmaceutical Inc.||0.63%||84.10||4.4%||$104.37m|
Intrexon Corp. operates as a biotechnology company. The company engages in the field of synthetic biology, which is an emerging discipline that applies engineering principles to biological systems. It designs, builds and regulates gene programs, which are DNA sequences that consist of key genetic components by using its suite of proprietary and complementary technologies. The company offers UltraVector proprietary technology platforms for the design, creation, modification, and regulation of complex gene programs and cellular systems at commercial scale; and RTS technology, which provides inducible control over the level and timing of gene expression and is part of an UltraVector library of various diverse modular genetic components. Intrexon was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.